TY - JOUR
T1 - Ca2+ handling and sensitivity in airway smooth muscle
T2 - Emerging concepts for mechanistic understanding and therapeutic targeting
AU - Koopmans, T.
AU - Anaparti, V.
AU - Castro-Piedras, I.
AU - Yarova, P.
AU - Irechukwu, N.
AU - Nelson, C.
AU - Perez-Zoghbi, J.
AU - Tan, X.
AU - Ward, J. P T
AU - Wright, D. B.
PY - 2014
Y1 - 2014
N2 - Free calcium ions within the cytosol serve as a key secondary messenger system for a diverse range of cellular processes. Dysregulation of cytosolic Ca2+ handling in airway smooth muscle (ASM) has been implicated in asthma, and it has been hypothesised that this leads, at least in part, to associated changes in both the architecture and function of the lung. Significant research is therefore directed towards furthering our understanding of the mechanisms which control ASM cytosolic calcium, in addition to those regulating the sensitivity of its downstream effector targets to calcium. Key aspects of the recent developments in this field were discussed at the 8th Young Investigators' Symposium on Smooth Muscle (2013, Groningen, The Netherlands), and are outlined in this review.
AB - Free calcium ions within the cytosol serve as a key secondary messenger system for a diverse range of cellular processes. Dysregulation of cytosolic Ca2+ handling in airway smooth muscle (ASM) has been implicated in asthma, and it has been hypothesised that this leads, at least in part, to associated changes in both the architecture and function of the lung. Significant research is therefore directed towards furthering our understanding of the mechanisms which control ASM cytosolic calcium, in addition to those regulating the sensitivity of its downstream effector targets to calcium. Key aspects of the recent developments in this field were discussed at the 8th Young Investigators' Symposium on Smooth Muscle (2013, Groningen, The Netherlands), and are outlined in this review.
KW - Airway smooth muscle
KW - Asthma
KW - Calcium
KW - Contraction
KW - Sensitisation
KW - WNT
UR - http://www.scopus.com/inward/record.url?scp=84922619525&partnerID=8YFLogxK
U2 - 10.1016/j.pupt.2014.05.001
DO - 10.1016/j.pupt.2014.05.001
M3 - Article
C2 - 24831539
AN - SCOPUS:84922619525
SN - 1094-5539
VL - 29
SP - 108
EP - 120
JO - Pulmonary pharmacology & therapeutics
JF - Pulmonary pharmacology & therapeutics
IS - 2
ER -